Search results for "Erythrocyte transfusion"

showing 10 items of 13 documents

Transfusion-dependency at presentation and its acquisition in the first year of diagnosis are both equally detrimental for survival in primary myelof…

2010

The International Prognostic Scoring System (IPSS) and karyotype are useful tools for risk stratification in primary myelofibrosis (PMF). We examined the additional prognostic impact of red blood cell transfusion need among 254 consecutive patients (median age, 59 years). Sixty-two patients ( approximately 24%) required transfusions at diagnosis whereas 22 ( approximately 9%) became transfusion-dependent and 170 remained transfusion-independent during the first year postdiagnosis; after a median follow-up of 55 months, the respective median survivals were 35, 25, and 117 months (P < 0.01). Multivariable analysis confirmed the IPSS- and karyotype-independent prognostic weight of transfusion …

AdultMalemedicine.medical_specialtytransfusion myelofibrosisPROGNOSISmedicine.medical_treatmentmyelofibrosisHematopoietic stem cell transplantationSeverity of Illness IndexSettore MED/15 - Malattie Del SangueRisk FactorsInternal medicineSeverity of illnessmedicineHumansMyelofibrosisSurvival analysisAgedRetrospective StudiesAged 80 and overChromosome AberrationsHematologybusiness.industryPatient SelectionMyelodysplastic syndromesHematopoietic Stem Cell TransplantationRetrospective cohort studyHematologyMiddle Agedmedicine.diseaseSurvival AnalysisSurgeryPrimary MyelofibrosisInternational Prognostic Scoring SystemRBC transfusiion; myelofibrosis; PROGNOSISFemaleErythrocyte TransfusionbusinessFollow-Up StudiesRBC transfusiionAmerican Journal of Hematology
researchProduct

Modulation of tumor oxygenation

1998

There is a large body of evidence suggesting that deficiencies in the O2 supply of tumors exist due to restrictions (i) in the O2 delivery by perfusion and/or diffusion, and (ii) in the O2 transport capacity. Whereas the former are mostly based on inadequate and heterogeneous microcirculatory functions, the latter are predominantly due to tumor-associated anemia. Possible uses and limitations of measures are discussed which can increase the microvascular O2 content and thus may preferentially serve to enhance diffusion-limited O2 availability. In addition, means are described for improving and increasing the uniformity of microcirculation thus possibly enhancing perfusion-limited O2 deliver…

Cancer ResearchErythrocyte transfusionPathologymedicine.medical_specialtyRadiationTumor hypoxiaCellular respirationbusiness.industryHyperbaric oxygenationOxygenationTumor OxygenationMicrocirculationOncologyCancer researchMedicineRadiology Nuclear Medicine and imagingbusinessPerfusionInternational Journal of Radiation Oncology*Biology*Physics
researchProduct

Intraoperative transfusion practices and perioperative outcome in the European elderly: A secondary analysis of the observational ETPOS study

2022

PLOS ONE 17(1), e0262110 (2022). doi:10.1371/journal.pone.0262110

Clinical OncologyMaleScienceClinical Decision-MakingCancer TreatmentSurgical and Invasive Medical ProceduresGeographical LocationsDiagnostic MedicineOutcome Assessment Health CareMedicine and Health SciencesHumansBlood TransfusionProspective StudiesAgedAged 80 and overIntraoperative CareMultidisciplinaryTransfusion MedicineQRAnemiaHematologyClinical Laboratory SciencesHealth CareEuropeSurgical OncologyOncologyAge GroupsElective Surgical ProceduresPeople and PlacesMedicinePopulation GroupingsFemaleGeriatric CareClinical MedicineErythrocyte TransfusionResearch ArticlePLOS ONE
researchProduct

Outcome of lower-risk patients with myelodysplastic syndromes without 5q deletion after failure of erythropoiesis-stimulating agents

2017

Purpose Most anemic patients with non-deleted 5q lower-risk myelodysplastic syndromes (MDS) are treated with erythropoiesis-stimulating agents (ESAs), with a response rate of approximately 50%. Second-line treatments, including hypomethylating agents (HMAs), lenalidomide (LEN), and investigational drugs, may be used after ESA failure in some countries, but their effect on disease progression and overall survival (OS) is unknown. Here, we analyzed outcome after ESA failure and the effect of second-line treatments. Patients and Methods We examined an international retrospective cohort of 1,698 patients with non-del(5q) lower-risk MDS treated with ESAs. Results Erythroid response to ESAs was 6…

MaleCancer Research0302 clinical medicineRecurrenceRisk Factorshemic and lymphatic diseasesHydroxyureaCumulative incidenceTreatment FailureEnzyme InhibitorsLenalidomideAged 80 and overCytarabineAnemiaMiddle AgedThalidomideMelodysplastic syndromeSurvival RateLeukemia Myeloid AcuteOncologyInternational Prognostic Scoring System030220 oncology & carcinogenesisRetreatmentAzacitidineCyclosporineDisease ProgressionChromosomes Human Pair 5FemaleChromosome DeletionErythrocyte Transfusionmedicine.drugmedicine.medical_specialtyMelodysplastic syndrome erytropoiesis stimulating agents 5q-erytropoiesis stimulating agentsDecitabineAntineoplastic AgentsTretinoinDecitabineLower risk5q-Arsenic03 medical and health sciencesInternal medicinemedicineHumansImmunologic FactorsSurvival rateAgedAntilymphocyte SerumRetrospective StudiesLenalidomidebusiness.industryValproic AcidMyelodysplastic syndromesRetrospective cohort studymedicine.diseaseMyelodysplastic SyndromesHematinicsPhysical therapybusiness030215 immunology
researchProduct

Red blood cell transfusion in perioperative pediatric anesthesia: a survey of current practice in Germany.

2018

BACKGROUND Little is known about the current practice of the perioperative transfusion of red blood cells (RBCs) in pediatric patients. This study was performed to evaluate the practice of RBC transfusion in German pediatric anesthesia. STUDY DESIGN AND METHODS An online survey was conducted among members of the German Society of Anesthesiology and Intensive Care. Participants were asked to indicate the hemoglobin (Hb) thresholds for starting RBC transfusion in six cases of different bleeding situations in pediatric anesthesia. Demographics of participants, general knowledge, and application of transfusion rules and guidelines were assessed. RESULTS We included 1207 of 1396 returned questio…

MalePediatricsmedicine.medical_specialtyBlood transfusionAdolescentCritical Caremedicine.medical_treatmentImmunology030204 cardiovascular system & hematology03 medical and health sciencesHemoglobins0302 clinical medicine030202 anesthesiologyInterquartile rangeIntensive careAnesthesiologyGermanySurveys and QuestionnairesImmunology and AllergyMedicineHumansAnesthesiaChildPerioperative Periodbusiness.industryInfant NewbornInfantHematologyGuidelinePerioperativeCurrent practiceFemalePediatric anesthesiabusinessErythrocyte TransfusionTransfusionREFERENCES
researchProduct

Tumor Oxygenation in Anemic Rats: Effects of Erythropoietin Treatment Versus Red Blood Cell Transfusion

1995

Anemia was induced in rats by the development of a hemorrhagic ascites. These animals also bore solid tumors (DS-sarcomas) on the hind foot dorsum. The effects of two methods for anemia correction on oxygenation in the solid tumors were compared in this study. Anemia was corrected either chronically by erythropoietin administration (1000 IU/kg) over 14 days (EPO) or acutely by transfusion with red blood cells (TR). Non-anemic and untreated anemic animals served as controls. Tumor oxygenation was determined in anesthetized animals using polarographic needle electrodes and pO2 histography. The reduction in hematocrit and hemoglobin content found in anemic animals could successfully be correct…

Malemedicine.medical_specialtyAnemiaPartial PressureBlood PressureHemorrhageHindlimbHematocritGastroenterologyRats Sprague-DawleyHemoglobinsOxygen Consumptionhemic and lymphatic diseasesInternal medicineAnimalsHumansMedicineRadiology Nuclear Medicine and imagingErythropoietinmedicine.diagnostic_testbusiness.industryAnemiaHematologyGeneral MedicineOxygenationCarbon DioxideHydrogen-Ion ConcentrationTumor Oxygenationmedicine.diseaseRecombinant ProteinsHindlimbRatsSurgeryOxygenBlood pressureHematocritOncologyErythropoietinSarcoma ExperimentalHemoglobinErythrocyte Transfusionbusinessmedicine.drugActa Oncologica
researchProduct

Blood Infusion and the Risk of Haemorrhage in Patients Undergoing Cardiac Surgery with Extracorporeal Circulation.

2016

Purpose: Patients undergoing cardiac surgery with extracorporeal circulation (ECC) frequently present haemorrhages as a complication associated with high morbidity and mortality. One of the factors that influences this risk is the volume of blood infused during surgery. The objective of this study was to determine the optimal volume of autologous blood that can be processed during cardiac surgery with ECC. We also determined the number of salvaged red blood cells to be reinfused into the patient in order to minimize the risk of haemorrhage in the postoperative period. Methods: This was an observational retrospective cross-sectional study performed in 162 ECC cardiac surgery patients. Data r…

Malemedicine.medical_specialtyAutologous bloodBlood volumeHemorrhageHigh morbidityRisk FactorsMedicineHumansIn patientPostoperative PeriodInfusion PumpsAgedRetrospective StudiesPharmacologyBlood VolumeReceiver operating characteristicbusiness.industryExtracorporeal circulationThoracic Surgical ProceduresSurgeryCardiac surgeryCross-Sectional StudiesROC CurveAnesthesiaFemaleCardiology and Cardiovascular MedicineComplicationbusinessErythrocyte TransfusionCurrent vascular pharmacology
researchProduct

Effects of red blood cell transfusion on anemia-related symptoms in patients with cancer.

2009

The aim of this study was to assess the effects of red blood cell transfusion, and the subsequent increase in hemoglobin values, on anemia-related symptoms in a cohort of patients with cancer with different survival times. A red blood cell transfusion was recommended to a consecutive sample of patients with hemoglobin levels of 8 +/- 0.5 g/dL. The number of units to be ordered was decided according the hemoglobin values with a mean target of increasing the hemoglobin values by approximately 2 g/dL. Hemoglobin values, anemia-related signs and symptoms, including well-being, fatigue, and dyspnea, were recorded at admission (T0), 1 day after the last transfusion (T1), and 15 days afterward (T2…

Malemedicine.medical_specialtyBlood transfusionAnemiamedicine.medical_treatmentRed Blood Cell TransfusionSettore MED/41 - AnestesiologiaNeoplasmsOutcome Assessment Health CaremedicineHumansIn patientGeneral NursingAgedcritical care in cancer patientsbusiness.industryCancerAnemiaGeneral MedicineMiddle Agedmedicine.diseaseConfidence intervalSurgeryAnesthesiology and Pain MedicineAnesthesiaCohortFemaleHemoglobinbusinessErythrocyte TransfusionJournal of palliative medicine
researchProduct

Elevation of plasma viscosity induces sustained NO-mediated dilation in the hamster cremaster microcirculation in vivo

1997

We studied whether a flow-independent increase of luminal wall shear stress (WSS) could dilate hamster arterioles in vivo and which endothelial mediators are potentially involved. To this end the plasma viscosity was elevated by exchanging blood for dextran-erythrocyte solution thereby augmenting WSS. Diameters of small and large arterioles as well as red blood cell velocities were measured before and after exchange of blood for solutions of identical haematocrit containing either high- (HMWD) or low-molecular weight dextran (LMWD). The potential role of endothelial autacoids was investigated by local application of the NO-synthase inhibitor NG-nitro-L-arginine (L-NNA), the inhibitor of cyc…

Malemedicine.medical_specialtyEndotheliumPhysiologyClinical BiochemistryPlasma SubstitutesHamsterGenitalia MaleNitric OxideMicrocirculationPlasmachemistry.chemical_compoundIn vivoCricetinaePhysiology (medical)Internal medicinePotassium Channel BlockersmedicineAnimalsBlood TransfusionCyclooxygenase InhibitorsMesocricetusMusclesDextransAnatomyBlood ViscosityMolecular WeightVasodilationArteriolesRed blood cellDextranmedicine.anatomical_structureEndocrinologychemistrycardiovascular systemDilation (morphology)Stress MechanicalNitric Oxide SynthaseErythrocyte TransfusionAutacoidcirculatory and respiratory physiologyPfl�gers Archiv European Journal of Physiology
researchProduct

Clinical and financial analysis of an acute palliative care unit in an oncological department

2008

The aim of this article is to describe the clinical activity and medical intervention of an acute model of palliative care unit (APC), as well as the reimbursement procedures and economic viability. A sample of 504 patients admitted at an APC in 1 year was surveyed. Indications for admission, pain and symptom intensity, analgesic treatments, procedures, instrumental examinations and modalities of discharge were recorded. For each patient, tariff for reimbursement was calculated according to the existent disease related grouping (DRG) system. The mean age was 62 years, and 246 patients were males. The mean hospital stay was 5.4 days. Pain control was the most frequent indication for admissi…

Malemedicine.medical_specialtyPalliative carePainSettore MED/42 - Igiene Generale E ApplicataUnit (housing)Economic viabilityIntervention (counseling)NeoplasmscostmedicineFinancial analysisTerminal careHumansProspective StudiesIntensive care medicinepain and symptom controlReimbursementCancerTerminal Carepalliative carebusiness.industryDelivery of Health Care IntegratedGeneral MedicineMiddle AgedAnalgesics OpioidAnesthesiology and Pain MedicineTreatment OutcomeItalyEmergency medicineInsurance Health ReimbursementFemaleOpioid analgesicsbusinessErythrocyte TransfusionDelivery of Health Care
researchProduct